Robert P. Whitehead
Department of Internal Medicine
University of Texas Medical Branch
301 University Blvd
Galveston
USA
Name/email consistency: high
- A Phase II trial of epothilone B analogue BMS-247550 (NSC #710428) ixabepilone, in patients with advanced pancreas cancer: a Southwest Oncology Group study. Whitehead, R.P., McCoy, S., Rivkin, S.E., Gross, H.M., Conrad, M.E., Doolittle, G.C., Wolff, R.A., Goodwin, J.W., Dakhil, S.R., Abbruzzese, J.L. Invest. New. Drugs (2006)
- Phase II trial of recombinant human interleukin-4 in patients with advanced renal cell carcinoma: a southwest oncology group study. Whitehead, R.P., Lew, D., Flanigan, R.C., Weiss, G.R., Roy, V., Glode, M.L., Dakhil, S.R., Crawford, E.D. J. Immunother. (2002)